BIC ONE Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation
- Coordinator
- Cortec GmbH, Germany
- Runs
- 1 November 2022 to 31 October 2024
- Status
- Finished
- EU funding
- €2.5m
- Total cost
- €3.7m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190118958
What the project is doing
In the project's own words, from its summary on CORDIS.
Electrical brain stimulation has been successfully used since the 1990s to treat neurological illnesses, particularly movement disorders. Most of the devices for this novel approach are based on the old pacemaker technology. Companies are unwilling to take device development risks & rely on established tech, limiting new therapy developments. Many neurological diseases are still treated with pharmaceuticals only, which has limited effectiveness and causes severe side effects.
Neuromodulation—electrical stimulation research has increased in recent decades. Additional recording capabilities & closed loop therapy expand therapeutic options. CorTec aims to provide novel implantable tech to overcome the current limitations: it enables researchers, medical institutions & industry to develop new therapies & devices. We plan to finalise the development of our tech for stroke rehabilitation, conduct clinical trials & get market approval in 2029, generating €250M in sales in 2030.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Cortec GmbH | Freiburg Im Breisgau | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI